Orion completes acquisition of LegoChem Biosciences

Reporter Kim SangJin / approved : 2024-04-01 03:57:19
  • -
  • +
  • 인쇄

(Photo = Yonhap news)

 

[Alpha Biz=(Chicago) Reporter Paul Lee] Orion said it has become the largest shareholder after paying 548.5 billion won in stock prices to acquire a 25.73% stake in LegoChem Biosciences.

Orion participated in LegoChem Biosciences's third-party paid-in capital increase and was allocated 7,963,283 shares for 59,000 won. It purchased 1.4 million old shares at a base price of 56,186 won from its founder Kim Yong-joo and CEO Park Se-jin to secure a total of 9,363,283 shares.

It plans to develop new drugs through its affiliate LegoChem Biosciences and complete its business portfolio for the group's sustainable growth.

 

 

Alphabiz Reporter Kim SangJin(hoondork1977@alphabiz.co.kr)

주요기사

Hyundai Motor Group Restores Vehicle Control Apps After 10-Hour Outage2025.09.18
HMM Completes Share Buyback Worth KRW 2.14 Trillion2025.09.18
Gyeonggi Police Arrest Two Chinese Nationals Over KT Mobile Payment Hacking Scheme2025.09.18
Financial Services Commission Imposes ₩3.66 Billion in Fines on STX and STX Marine Service for Accounting Violations Related to Overseas Litigation2025.09.18
Kakao Union Protests Mandatory Forensic Consent, Demands Immediate Withdrawal2025.09.18
뉴스댓글 >